Abstract Details

Title Interim Results of an Open-Label Study to Assess the Effects of Delayed-release Dimethyl Fumarate on Lymphocyte Subsets and Immunoglobulins in Patients with Relapsing-remitting Multiple Sclerosis

Topic Multiple Sclerosis

Presentation(s) P5 - (-)

Poster/Presentation
Number 380

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Christian Von Hehn, MD, PhD PRESENTER	Dr. Von Hehn has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Von Hehn has stock in Takeda Pharmaceuticals.
Devangi S. Mehta, PhD (Biogen)	No disclosure on file
Claudia Prada	No disclosure on file
	No disclosure on file
Shifang Liu	No disclosure on file
Soma S. Ray	Soma S. Ray has received personal compensation for serving as an employee of Dyne Therapeutics. Soma S. Ray has stock in Dyne Therapeutics.
Sarah I. Sheikh, BM Bch, MSc, MRCP, FAAN	Dr. Sheikh has received personal compensation for serving as an employee of Takeda.

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��